AXQ Capital LP boosted its position in shares of Genpact Limited (NYSE:G - Free Report) by 60.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 25,801 shares of the business services provider's stock after purchasing an additional 9,696 shares during the quarter. AXQ Capital LP's holdings in Genpact were worth $1,108,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors also recently added to or reduced their stakes in the company. JPMorgan Chase & Co. boosted its stake in Genpact by 192.8% during the 3rd quarter. JPMorgan Chase & Co. now owns 3,129,341 shares of the business services provider's stock worth $122,701,000 after acquiring an additional 2,060,595 shares during the last quarter. Tandem Investment Advisors Inc. increased its holdings in Genpact by 390.5% during the 4th quarter. Tandem Investment Advisors Inc. now owns 2,129,915 shares of the business services provider's stock worth $91,480,000 after purchasing an additional 1,695,706 shares in the last quarter. Victory Capital Management Inc. raised its position in Genpact by 18.1% in the 4th quarter. Victory Capital Management Inc. now owns 9,853,437 shares of the business services provider's stock valued at $423,205,000 after buying an additional 1,511,790 shares during the last quarter. Geode Capital Management LLC raised its holdings in shares of Genpact by 12.6% in the third quarter. Geode Capital Management LLC now owns 3,691,406 shares of the business services provider's stock valued at $148,142,000 after purchasing an additional 413,646 shares during the last quarter. Finally, Swiss National Bank bought a new stake in Genpact during the 4th quarter worth about $14,298,000. 96.03% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of research firms have weighed in on G. Mizuho raised their price target on Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a research note on Monday, February 10th. Needham & Company LLC boosted their target price on shares of Genpact from $55.00 to $65.00 and gave the stock a "buy" rating in a report on Friday, February 7th. TD Cowen upgraded shares of Genpact from a "hold" rating to a "buy" rating and increased their price target for the company from $45.00 to $60.00 in a research note on Friday, February 7th. Finally, Jefferies Financial Group upgraded shares of Genpact from a "hold" rating to a "buy" rating and boosted their price objective for the stock from $44.00 to $55.00 in a research note on Tuesday, January 21st. Six equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Hold" and an average price target of $48.44.
Get Our Latest Report on G
Genpact Stock Performance
Shares of NYSE:G traded down $0.22 on Wednesday, reaching $50.36. 2,098,063 shares of the company's stock were exchanged, compared to its average volume of 1,298,432. The company has a current ratio of 2.16, a quick ratio of 1.85 and a debt-to-equity ratio of 0.50. Genpact Limited has a twelve month low of $30.23 and a twelve month high of $56.76. The company has a fifty day moving average of $50.50 and a 200-day moving average of $44.86. The company has a market capitalization of $8.85 billion, a price-to-earnings ratio of 17.73, a PEG ratio of 1.84 and a beta of 1.16.
Genpact (NYSE:G - Get Free Report) last released its earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share for the quarter, missing analysts' consensus estimates of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. On average, research analysts predict that Genpact Limited will post 3.21 EPS for the current fiscal year.
Genpact Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Tuesday, March 11th will be given a $0.17 dividend. The ex-dividend date is Tuesday, March 11th. This is a boost from Genpact's previous quarterly dividend of $0.15. This represents a $0.68 annualized dividend and a dividend yield of 1.35%. Genpact's payout ratio is presently 23.94%.
Insider Transactions at Genpact
In other Genpact news, CEO Balkrishan Kalra sold 13,600 shares of the firm's stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $48.89, for a total value of $664,904.00. Following the sale, the chief executive officer now owns 310,246 shares in the company, valued at $15,167,926.94. This trade represents a 4.20 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, SVP Piyush Mehta sold 12,000 shares of the company's stock in a transaction on Friday, January 10th. The stock was sold at an average price of $42.83, for a total transaction of $513,960.00. Following the transaction, the senior vice president now owns 151,182 shares of the company's stock, valued at $6,475,125.06. This trade represents a 7.35 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.80% of the stock is currently owned by insiders.
Genpact Profile
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
See Also

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report